APM

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Aptorum Group Ltd Class A

NASDAQ | APM

1.92

USD

+$0.00

(

+0.00%

)

At Close (As of Sep 18, 2025)

$12.86M

Market Cap

-

P/E Ratio

-0.78

EPS

$4.47

52 Week High

$0.46

52 Week Low

HEALTHCARE

Sector

APM Chart

Recent Chart
Price Action

APM Technicals

Tags:

APM Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$255K
Total Revenue $0
Cost Of Revenue $255K
Costof Goods And Services Sold $255K
Operating Income -$3.8M
Selling General And Administrative $1.5M
Research And Development $1.9M
Operating Expenses $3.5M
Investment Income Net -
Net Interest Income -$147K
Interest Income -
Interest Expense $147K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $255K
Income Before Tax -$4.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$4.2M
Comprehensive Income Net Of Tax -
Ebit -$4M
Ebitda -$3.8M
Net Income -$4.3M

Revenue & Profitability

Earnings Performance

APM Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $16M
Total Current Assets $960K
Cash And Cash Equivalents At Carrying Value $874K
Cash And Short Term Investments $874K
Inventory -
Current Net Receivables $0
Total Non Current Assets $15M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $15M
Short Term Investments -
Other Current Assets -
Other Non Current Assets -
Total Liabilities $4.4M
Total Current Liabilities $4.3M
Current Accounts Payable -
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $14K
Capital Lease Obligations $116K
Long Term Debt -
Current Long Term Debt $3.2M
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities -
Other Non Current Liabilities -
Total Shareholder Equity $21M
Treasury Stock -
Retained Earnings -$72M
Common Stock -
Common Stock Shares Outstanding $5.5M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$1.2M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $306K
Capital Expenditures $0
Change In Receivables -
Change In Inventory $0
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $0
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$4.3M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$255K
Total Revenue $0
Cost Of Revenue $255K
Costof Goods And Services Sold $255K
Operating Income -$3.8M
Selling General And Administrative $1.5M
Research And Development $1.9M
Operating Expenses $3.5M
Investment Income Net -
Net Interest Income -$147K
Interest Income -
Interest Expense $147K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $255K
Income Before Tax -$4.2M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$4.2M
Comprehensive Income Net Of Tax -
Ebit -$4M
Ebitda -$3.8M
Net Income -$4.3M

APM News

APM Profile

Aptorum Group Ltd Class A Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Aptorum Group Ltd Class A is a biotech company based in London, UK, focused on the discovery, development, and commercialization of innovative therapeutic products, primarily targeting infectious diseases and cancers. The company's commitment to addressing unmet medical needs is underscored by its diverse pipeline of drug candidates, which leverage advanced research and proprietary technologies. With a strategic emphasis on bringing novel treatments to market, Aptorum Group is positioned to make a significant impact in the pharmaceutical landscape.

ADAP
+98.01%
$0.16
INTC
+22.77%
$30.57
DVLT
+21.00%
$0.41
CGBS
-39.47%
$0.03
NVDA
+3.49%
$176.24
AERT
+63.84%
$0.93
BITF
+4.91%
$3.20
SNAP
+6.32%
$8.49
GPUS
+30.65%
$0.53
ATCH
-28.08%
$1.16
PLUG
+5.00%
$2.10
LASE
+69.10%
$4.73
CDLX
+109.79%
$3.00
RAYA
+35.57%
$0.06
RGTI
+12.50%
$24.74
AAL
+0.80%
$12.58
APVO
+38.96%
$1.95
GRAB
+4.09%
$6.35
TSLA
-2.11%
$416.85
ETNB
+85.14%
$14.96
AMD
-0.77%
$157.91
MARA
+6.68%
$18.50
SOUN
+3.47%
$15.64
QBTS
+6.56%
$24.02
NIO
-1.14%
$7.36
SOFI
+3.57%
$28.11
TPIC
-45.91%
$0.12
PLTR
+5.13%
$176.97
YAAS
+14.04%
$0.07
AXDX
-61.36%
$0.03
BINI
-16.93%
$0.05
QS
+18.22%
$12.13
BMNR
+4.78%
$59.80
CLSK
+17.65%
$13.46
TNMG
-0.27%
$0.32
DNN
+1.18%
$2.57
CJET
+9.27%
$0.10
F
+0.72%
$11.74
LYT
-16.77%
$0.09
NFE
+12.96%
$2.44
TLRY
+5.88%
$1.26
BTG
-0.23%
$4.32
VHAI
0.00%
$0.00
RR
+12.81%
$4.49
IONQ
+2.09%
$66.81
ABEV
-2.54%
$2.29
BBD
-1.20%
$3.27
AAPL
-0.46%
$237.88
FAAS
-10.53%
$0.08
MULN
-6.96%
$0.06
RMBL
+60.50%
$3.21
RIVN
+5.42%
$14.87
QUBT
+4.06%
$18.43
ADD
-25.47%
$0.05
AMZN
-0.16%
$231.23
HIMS
+11.55%
$56.17
CIFR
-4.28%
$11.85
ONDS
+8.19%
$6.60
JOBY
+3.24%
$14.62
BURU
+5.71%
$0.14
ACHR
+2.77%
$9.25
SRM
+53.27%
$10.30
QSI
+21.82%
$1.53
KDLY
+4.19%
$1.49
WBD
+3.44%
$18.60
PFE
+0.41%
$24.15
WULF
-1.58%
$11.17
KEY
+2.24%
$19.13
HBAN
+1.88%
$17.87
IONZ
-4.37%
$4.59
IXHL
+2.29%
$0.54
NVNI
+11.78%
$0.90
NOK
+1.38%
$4.76
ORIS
+9.39%
$0.15
HOOD
+2.24%
$121.29
BTE
-2.29%
$2.54
UEC
+0.16%
$12.26
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BEEM
+20.15%
$3.04
MRVL
+4.57%
$74.23
WLGS
-5.57%
$0.04
SBET
+0.58%
$17.22
MU
+5.56%
$168.89
OKLO
+10.10%
$104.92
AIRE
-10.40%
$1.12
REPL
-39.40%
$3.46
VALE
-0.36%
$10.84
KVUE
-1.30%
$18.10
HL
-2.26%
$10.78
ETWO
0.00%
$3.30
NVTS
+4.17%
$6.73
RCAT
-10.91%
$10.03
JD
+0.39%
$35.38
RIG
+1.76%
$3.46
SMCI
+2.31%
$45.94
NAKA
+3.50%
$1.48
BTBT
+2.97%
$3.12
CAN
+1.23%
$0.81
PBM
+42.47%
$5.30
ADAP
+98.01%
$0.16
INTC
+22.77%
$30.57
DVLT
+21.00%
$0.41
CGBS
-39.47%
$0.03
NVDA
+3.49%
$176.24
AERT
+63.84%
$0.93
BITF
+4.91%
$3.20
SNAP
+6.32%
$8.49
GPUS
+30.65%
$0.53
ATCH
-28.08%
$1.16
PLUG
+5.00%
$2.10
LASE
+69.10%
$4.73
CDLX
+109.79%
$3.00
RAYA
+35.57%
$0.06
RGTI
+12.50%
$24.74
AAL
+0.80%
$12.58
APVO
+38.96%
$1.95
GRAB
+4.09%
$6.35
TSLA
-2.11%
$416.85
ETNB
+85.14%
$14.96
AMD
-0.77%
$157.91
MARA
+6.68%
$18.50
SOUN
+3.47%
$15.64
QBTS
+6.56%
$24.02
NIO
-1.14%
$7.36
SOFI
+3.57%
$28.11
TPIC
-45.91%
$0.12
PLTR
+5.13%
$176.97
YAAS
+14.04%
$0.07
AXDX
-61.36%
$0.03
BINI
-16.93%
$0.05
QS
+18.22%
$12.13
BMNR
+4.78%
$59.80
CLSK
+17.65%
$13.46
TNMG
-0.27%
$0.32
DNN
+1.18%
$2.57
CJET
+9.27%
$0.10
F
+0.72%
$11.74
LYT
-16.77%
$0.09
NFE
+12.96%
$2.44
TLRY
+5.88%
$1.26
BTG
-0.23%
$4.32
VHAI
0.00%
$0.00
RR
+12.81%
$4.49
IONQ
+2.09%
$66.81
ABEV
-2.54%
$2.29
BBD
-1.20%
$3.27
AAPL
-0.46%
$237.88
FAAS
-10.53%
$0.08
MULN
-6.96%
$0.06
RMBL
+60.50%
$3.21
RIVN
+5.42%
$14.87
QUBT
+4.06%
$18.43
ADD
-25.47%
$0.05
AMZN
-0.16%
$231.23
HIMS
+11.55%
$56.17
CIFR
-4.28%
$11.85
ONDS
+8.19%
$6.60
JOBY
+3.24%
$14.62
BURU
+5.71%
$0.14
ACHR
+2.77%
$9.25
SRM
+53.27%
$10.30
QSI
+21.82%
$1.53
KDLY
+4.19%
$1.49
WBD
+3.44%
$18.60
PFE
+0.41%
$24.15
WULF
-1.58%
$11.17
KEY
+2.24%
$19.13
HBAN
+1.88%
$17.87
IONZ
-4.37%
$4.59
IXHL
+2.29%
$0.54
NVNI
+11.78%
$0.90
NOK
+1.38%
$4.76
ORIS
+9.39%
$0.15
HOOD
+2.24%
$121.29
BTE
-2.29%
$2.54
UEC
+0.16%
$12.26
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BEEM
+20.15%
$3.04
MRVL
+4.57%
$74.23
WLGS
-5.57%
$0.04
SBET
+0.58%
$17.22
MU
+5.56%
$168.89
OKLO
+10.10%
$104.92
AIRE
-10.40%
$1.12
REPL
-39.40%
$3.46
VALE
-0.36%
$10.84
KVUE
-1.30%
$18.10
HL
-2.26%
$10.78
ETWO
0.00%
$3.30
NVTS
+4.17%
$6.73
RCAT
-10.91%
$10.03
JD
+0.39%
$35.38
RIG
+1.76%
$3.46
SMCI
+2.31%
$45.94
NAKA
+3.50%
$1.48
BTBT
+2.97%
$3.12
CAN
+1.23%
$0.81
PBM
+42.47%
$5.30
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.